FEMSelect

FEMSelect was built around EnPlace®, our game-changing, minimally invasive solution for pelvic organ prolapse. 50% of women will suffer from prolapse in her lifetime, experiencing life-altering symptoms such as incontinence, pain and difficulty with sexual intercourse. With EnPlace, women experience minimal pain and recover in days. We've built a small but highly effective commercial team in the US, backed by a growing international distribution network in LatAm and Europe, and over the past year, we have assembled a portfolio of partnerships that reflects the opportunity in women's health. In the US, FEMSelect is the national distributor for Elidah's Elitone, a non-invasive incontinence solution and recently negotiated a distribution partnership with AlloSource, a non-profit tissue bank, to represent their biologic portfolio for pelvic health procedures.